Rameda launches initiative for the complementary dispensary and home delivery of medication at no cost, underlining its dedication to ensuring the healthcare and safety among Egypt’s most immune-compromised patient populations amid the COVID-19 pandemic

Rameda, is pleased to announces today the launch of Rameda’s SPP (“Save Yourself, Stay Home, Protect your Family, Protect your Community”) project, aimed at reducing elderly and patients with special needs’ risk of exposure to COVID-19 through the electronic dispensary and home delivery of cardiovascular, diabetes and gastroenterology-related products manufactured by Rameda, free of charge. This value-added service was created with the objective to enable social-distancing across the commonly immune-compromised population of Egypt who suffer from non-communicable diseases, namely cardiovascular disease, diabetes mellitus and gastro-intestinal diseases, and to provide them with the essential medicines they need from Rameda’s product portfolio to help them reach their desired treatment goals. Each delivery will be conducted in a quick, efficient and safe manner and will further include safety tips on how patients can protect themselves against Coronavirus.

Rameda will work in tandem with a large network of more than 400 pre-approved licensed doctors and physicians, who will first determine whether their patient’s health profile matches Rameda’s clearly defined criteria as immune-compromised. These patients are selected by their doctors based on clear, defined criteria to include the elderly, and patients who suffer from the previously mentioned non-communicable diseases and are unable to afford the medication. The doctor or physician will then direct eligible patients to send a screenshot of their valid prescription along with their necessary details, including name, age, address and contact, to a designated number. Patients will receive their free medication at their residence within three working days for a contactless delivery, free of charge.

The 3-month project is being rolled out in 3 phases, with each phase closely monitored by Rameda to decide on the continuity of the project based on our assessment and evaluation of its success to date in addition to the state of the Coronavirus pandemic in Egypt. During the first phase of the project, which began in April 19th, more than 165 cardiologists and diabetologists from our approved list of physicians across Cairo and Alexandria were included in the project after receiving letters inviting them to become part of the initiative, with directions and the contact number for their patients to send across their prescription screenshots. The second phase, subject to the successful evaluation and assessment of the first phase’s roll-out, will see the project expand to include more than 140 cardiologists and diabetologists from Delta & Canal and Upper Egypt regions, and the third and final phase will include a further 100 gastroenterologists across Egypt. An initial tele-survey conducted by Rameda’s medical sales team showed the greater majority of Cardiologists, Diabetologists and Gastroenterologists across our network to be on board with the new initiative as an effective way to minimize the risk of Rameda’s long-time clients’ exposure to the unprecedented pandemic.

“The SPP initiative was created to provide our most immune-compromised patients across Egypt who suffer from non-communicable cardiovascular, diabetes and gastrointestinal conditions with a safe and secure way to receive their much-deserved treatment” said Rameda CEO Dr. Amr Morsy. “In just under two weeks, our dedicated task force team has cultivated the initiative from an idea to fruition, ensuring not only business continuity for the Group, but also a safe route for our high-risk patients to receive the healthcare they need in the safest possible manner.”